Child Neurology: Infantile Biotin Thiamine Responsive Basal Ganglia Disease: Case Report and Brief Review.

Publication/Presentation Date

4-25-2023

Abstract

Biotin thiamine responsive basal ganglia disease (BTRBGD) is an inherited autosomal recessive disorder that results from the inability of thiamine to cross the blood-brain barrier. It is considered a treatable condition if vitamin supplementation, most commonly with thiamine and biotin, is initiated early. BTRBGD can present as an infantile form, classical childhood form, or adult Wernicke-like encephalopathy. The infantile form is often the most severe and portends a worse prognosis with high mortality despite vitamin supplementation. We present a two-month-old who presented with irritability, opisthotonos, and abnormal eye movements who was found to have compound heterozygous variants in the

Volume

100

Issue

17

First Page

836

Last Page

839

ISSN

1526-632X

Disciplines

Medicine and Health Sciences | Pediatrics

PubMedID

36657988

Department(s)

Department of Pediatrics

Document Type

Article

Share

COinS